Literature DB >> 8781270

Human tumor antigens are ready to fly.

R A Henderson1, O J Finn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8781270     DOI： 10.1016/s0065-2776(08)60431-9

Source DB:  PubMed          Journal:  Adv Immunol        ISSN： 0065-2776            Impact factor:   3.543


× No keyword cloud information.
  10 in total

Review 1.  Progress on new vaccine strategies for the immunotherapy and prevention of cancer.

Authors:  Jay A Berzofsky; Masaki Terabe; SangKon Oh; Igor M Belyakov; Jeffrey D Ahlers; John E Janik; John C Morris
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

Review 2.  The dawn of vaccines for cancer prevention.

Authors:  Olivera J Finn
Journal:  Nat Rev Immunol       Date:  2017-12-27       Impact factor: 53.106

3.  Genetic vaccination with "self" tyrosinase-related protein 2 causes melanoma eradication but not vitiligo.

Authors:  V Bronte; E Apolloni; R Ronca; P Zamboni; W W Overwijk; D R Surman; N P Restifo; P Zanovello
Journal:  Cancer Res       Date:  2000-01-15       Impact factor: 12.701

Review 4.  Vaccines for cancer prevention: a practical and feasible approach to the cancer epidemic.

Authors:  Olivera J Finn
Journal:  Cancer Immunol Res       Date:  2014-08       Impact factor: 11.151

5.  Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*2402.

Authors:  Toshiyuki Baba; Marimo Sato-Matsushita; Akira Kanamoto; Akihiko Itoh; Naoki Oyaizu; Yusuke Inoue; Yutaka Kawakami; Hideaki Tahara
Journal:  J Transl Med       Date:  2010-09-16       Impact factor: 5.531

6.  Ubiquitin-fusion degradation pathway plays an indispensable role in naked DNA vaccination with a chimeric gene encoding a syngeneic cytotoxic T lymphocyte epitope of melanocyte and green fluorescent protein.

Authors:  Manxin Zhang; Kazunari Ishii; Hajime Hisaeda; Shigeo Murata; Tomoki Chiba; Keiji Tanaka; Yang Li; Chikage Obata; Masutaka Furue; Kunisuke Himeno
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

7.  p53 and HLA class-I expression are not down-regulated in colorectal cancer liver metastases.

Authors:  Anand G Menon; Rob A E M Tollenaar; Cornelis J H van de Velde; Hein Putter; Connie M Janssen-van Rhijn; Rob Keijzer; Gert Jan Fleuren; Peter J K Kuppen
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

8.  Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells.

Authors:  H Kao; J A Marto; T K Hoffmann; J Shabanowitz; S D Finkelstein; T L Whiteside; D F Hunt; O J Finn
Journal:  J Exp Med       Date:  2001-11-05       Impact factor: 14.307

Review 9.  Strategies for developing and optimizing cancer vaccines.

Authors:  Hoyoung M Maeng; Jay A Berzofsky
Journal:  F1000Res       Date:  2019-05-13

10.  Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis.

Authors:  T Chiba; H Ohtani; T Mizoi; Y Naito; E Sato; H Nagura; A Ohuchi; K Ohuchi; K Shiiba; Y Kurokawa; S Satomi
Journal:  Br J Cancer       Date:  2004-11-01       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.